Is screening for chronic obstructive pulmonary disease justified?

被引:15
作者
Badgett, RG
Tanaka, DJ
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT INTERNAL MED, SAN ANTONIO, TX 78284 USA
[2] UNIV COLORADO, HLTH SCI CTR, DEPT INTERNAL MED, BOULDER, CO 80309 USA
关键词
emphysema; spirometry; screening; smoking cessation;
D O I
10.1006/pmed.1997.0177
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Many experts recommend spirometry to screen for chronic obstructive pulmonary disease (COPD) in asymptomatic patients; however, evidence for this recommendation has not been systematically reviewed. Methods. We examined whether screening spirometry meets standard criteria for effective screening. We performed structured searches of MEDLINE, followed by a selective search of the CITATION index, to locate randomized trials of interventions for asymptomatic patients with COPD. In regard to smoking cessation, we included all controlled trials of smoking cessation programs that used spirometry. We also included all studies that assessed the ability of spirometry to predict successful smoking cessation by comparing baseline lung function in smokers who subsequently quit versus those who did not. Results. With the exception of smoking cessation, all interventions for COPD have only been proven effective in symptomatic patients. Two studies found that multifaceted smoking cessation programs that included spirometry were efficacious. There was no effect in a third study that isolated the role of spirometry. Smokers with abnormal spirometric results are less likely than other smokers to quit over the ensuing year. Conclusions. There is no evidence that spirometry, as an isolated intervention, aids smoking cessation. (C) 1997 Academic Press.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 86 条
  • [1] *AM MED SOC, 1994, PHYS CURR PROC TERM, P37
  • [2] *AM THOR SOC, 1983, AM REV RESPIR DIS, V128, P768
  • [3] ANDA RF, 1987, JAMA-J AM MED ASSOC, V257, P1916
  • [4] LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES
    不详
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05): : 1202 - 1218
  • [5] [Anonymous], 1996, GUID CLIN PREV SERV
  • [6] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY
    ANTHONISEN, NR
    CONNETT, JE
    KILEY, JP
    ALTOSE, MD
    BAILEY, WC
    BUIST, AS
    CONWAY, WA
    ENRIGHT, PL
    KANNER, RE
    OHARA, P
    OWENS, GR
    SCANLON, PD
    TASHKIN, DP
    WISE, RA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19): : 1497 - 1505
  • [7] THE CLINICAL-EVALUATION FOR DIAGNOSING OBSTRUCTIVE AIRWAYS DISEASE IN HIGH-RISK PATIENTS
    BADGETT, RG
    TANAKA, DJ
    HUNT, DK
    JELLEY, MJ
    FEINBERG, LE
    STEINER, JF
    PETTY, TL
    [J]. CHEST, 1994, 106 (05) : 1427 - 1431
  • [8] CAN MODERATE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE BE DIAGNOSED BY HISTORICAL AND PHYSICAL FINDINGS ALONE
    BADGETT, RG
    TANAKA, DJ
    HUNT, DK
    JELLEY, MJ
    FEINBERG, LE
    STEINER, JF
    PETTY, TL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1993, 94 (02) : 188 - 196
  • [9] REPLACEMENT THERAPY FOR HEREDITARY ALPHA(1)-ANTITRYPSIN DEFICIENCY - A PROGRAM FOR LONG-TERM ADMINISTRATION
    BARKER, AF
    SIEMSEN, F
    PASLEY, D
    DSILVA, R
    BUIST, AS
    [J]. CHEST, 1994, 105 (05) : 1406 - 1410
  • [10] PNEUMONIA AND INFLUENZA DEATHS DURING EPIDEMICS - IMPLICATIONS FOR PREVENTION
    BARKER, WH
    MULLOOLY, JP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (01) : 85 - 89